Calendula officinalis L. · herb
Evidence tier: traditional
Soothes and heals inflamed and irritated skin, effective for eczema, dermatitis, minor wounds, and rashes through flavonoid and triterpenoid action
Calendula's triterpenoids, chiefly the faradiol esters and oleanolic acid glycosides, carry the anti inflammatory activity, and the flavonoids and carotenoids add antioxidant effects; MSK describes modulation of antioxidant and inflammatory signalling and downregulation of TNF alpha. The wound healing story, that triterpenoid saponins drive fibroblast proliferation and collagen deposition and so close a wound faster, is supported in cell and animal work and is the standard explanation. It is a laboratory mechanism. The EMA registered calendula on tradition precisely because the human trials were not good enough to confirm it does this in people.
Traditional use, topical, and the one impressive trial did not replicate. Europe's regulator is the anchor and it is unambiguous: the EMA HMPC registers calendula flower on TRADITIONAL USE only, for minor skin inflammation such as sunburn, as an aid to the healing of minor wounds, and for minor inflammation of the mouth or throat. The HMPC's stated reason for the traditional registration is the honest one: 'although there is insufficient evidence from clinical trials, the effectiveness of these herbal medicines is plausible and there is evidence that they have been used safely in this way for at least 30 years.' The HMPC did look at the clinical studies on skin and found 'problems with the design of the studies' that prevented any firm conclusion. That is the whole verdict, and everything below is why. Calendula's famous result is the Pommier phase III trial (Journal of Clinical Oncology 2004, 254 women), in which calendula ointment beat trolamine for preventing acute radiation dermatitis during breast cancer radiotherapy: 41 percent versus 63 percent developed grade 2 or worse dermatitis. It is a real, well sized, positive trial. It also did not hold up. A LARGER randomised trial by Sharp and colleagues (411 breast cancer patients on adjuvant radiotherapy) compared calendula cream against a plain aqueous cream and found NO significant difference in severe skin reactions, quality of life, adherence, pain, itching or burning, and concluded that the skin product used made very little difference to radiation skin toxicity. When the bigger and better controlled trial finds nothing, the smaller positive one stops being a claim. Note also the disease population trap: even the positive result was in CANCER PATIENTS UNDERGOING RADIOTHERAPY, which is a highly specific clinical setting and cannot be carried across to a consumer soothing skin claim. Beyond radiotherapy: MSK reports preliminary signals for diabetic foot ulcers and venous leg ulcers that need larger confirmatory studies, a diaper dermatitis trial roughly comparable to aloe vera, and MIXED results for mucositis. MSK's own summary of the field: most studies are small; larger trials are needed. Calendula is a reasonable, gentle, traditional topical. It is not a clinically proven one.
Topical and oromucosal only. The EMA registers traditional preparations for application to the skin (liquid and semi solid forms) and as an infusion for rinsing the mouth, with age limits of over 6 years for skin use and over 12 years for use in the mouth. In the radiotherapy trial the ointment was applied to the irradiated field after each session. No effective concentration has been established by any regulator, so no percentage is asserted here. Internal use as a supplement is not supported: EMA does not register calendula for systemic effect, and MSK advises avoiding it in pregnancy and lactation for lack of safety data.
Topical: apply calendula cream or diluted tincture to affected areas 2 to 3 times daily. Internal (inflammation and gut support): take as a tea or tincture, 3 to 4 times daily. Particularly effective as a topical for sensitive and broken skin.
Onset: ~21 days
Excellent topical safety profile. Avoid in known Asteraceae/Compositae family allergy (marigold, chrysanthemum, ragweed cross reactivity). Systemic absorption from topical use is negligible. Internal use (teas) has limited safety data in pregnancy, use topically only.
Pregnancy: caution
Breastfeeding: safe
Used since the 12th century in European herbal medicine for wound healing, skin inflammation, and digestive complaints. Still widely used in traditional and folk medicine across Europe and the Middle East. Named after the Roman calendar (calendae) because it blooms throughout the month.
Active compounds: triterpenoid saponins (oleanolic acid glycosides), faradiol esters, isorhamnetin, narcissin, quercetin, lutein, beta-carotene, polysaccharides
Remedies using Calendula · Browse by body system · Check it against what you take
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.